Niemann-Pick Type C Disease Often Overlooked
Are you interested in learning more about Niemann-Pick type C disease?
Prof. Peter Bauer, CSO of CENTOGENE, introduces you to NP-C and discusses the importance of a robust biomarker for the diagnosis and monitoring of this disease.
Discover how our screening programs for NP-C can enable diagnosis, prediction and therapy monitoring for your patients.
Webinar Content:
- CENTOGENE’s integrated diagnostic concept for rare diseases
- The challenge with rare variant classification and medical interpretation
- The value of biomarkers in rare diseases – biomarkers in Niemann-Pick type C disease
Our Speaker
Prof. Peter Bauer, M.D.
Chief Medical and Genomic Officer, CENTOGENE
Prof. Peter Bauer, M.D., serves as CENTOGENE’s Chief Medical and Genomic Officer, where […]
Load content from Youtube?
By agreeing to load this content i accept to have my information shared with content provider (and it's partners). More info in our Privacy Policy.
